Pathophysiology Quiz: Uremia
20 questions · exam conditions
0:00
UremiaQuestion 1 of 20

A patient with Stage 5 CKD not yet on dialysis is noted to have fasting hyperglycemia. The patient has no prior history of diabetes. Which mechanism best explains this finding in the context of uremia?

Decreased renal clearance of insulin, leading to relative insulin excess.
Pancreatic beta-cell dysfunction and decreased insulin secretion.
Increased hepatic gluconeogenesis stimulated by excess glucagon.
Post-receptor defects in insulin signaling pathways in peripheral tissues.
← Back to quizzes

Pathophysiology Quiz

Pathophysiology Quiz: Uremia

Practice Uremia in Pathophysiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Uremia, giving you a quick way to practice the rules, question types, and explanations that matter most for Pathophysiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with Stage 5 CKD not yet on dialysis is noted to have fasting hyperglycemia. The patient has no prior history of diabetes. Which mechanism best explains this finding in the context of uremia?

  1. Decreased renal clearance of insulin, leading to relative insulin excess.
  2. Pancreatic beta-cell dysfunction and decreased insulin secretion.
  3. Increased hepatic gluconeogenesis stimulated by excess glucagon.
  4. Post-receptor defects in insulin signaling pathways in peripheral tissues. (correct answer)
Explanation: When you encounter hyperglycemia in advanced CKD patients without prior diabetes, you're dealing with uremic toxin-induced insulin resistance, a key pathophysiologic consequence of kidney failure. The correct mechanism is D) Post-receptor defects in insulin signaling pathways in peripheral tissues. In Stage 5 CKD, accumulated uremic toxins directly impair insulin signaling at the cellular level. These toxins interfere with insulin receptor substrate proteins and downstream signaling cascades in muscle and fat cells, preventing glucose uptake despite adequate insulin levels. This creates a state of insulin resistance where insulin is present but cannot effectively facilitate glucose entry into cells. A) Decreased renal clearance of insulin is actually true in CKD, but this would theoretically improve glucose control by maintaining higher insulin levels, not cause hyperglycemia. The insulin resistance from uremic toxins overwhelms this effect. B) Pancreatic beta-cell dysfunction can occur in very advanced uremia, but it's typically a later finding. The primary mechanism causing hyperglycemia in CKD is peripheral insulin resistance, not inadequate insulin production. C) Increased hepatic gluconeogenesis from excess glucagon isn't the primary driver here. While some metabolic derangements occur in uremia, the dominant mechanism is the direct toxic effect on peripheral insulin sensitivity. Study tip: Remember that uremic toxins are the villains in advanced CKD complications. When you see unexplained metabolic problems in Stage 4-5 CKD patients, think about how accumulated toxins are disrupting normal cellular processes—in this case, insulin signaling.

Question 2

How does the chronic metabolic acidosis associated with uremia directly contribute to renal osteodystrophy?

  1. It provides protons that are buffered by the release of calcium and carbonate from bone. (correct answer)
  2. It directly stimulates the parathyroid glands to release more PTH.
  3. It inhibits the renal 1-alpha-hydroxylase enzyme, acutely reducing calcitriol synthesis.
  4. It causes peripheral resistance to the action of PTH at the level of the osteoclast.
Explanation: When you encounter questions about renal osteodystrophy, focus on understanding how kidney disease creates a cascade of mineral and bone disorders through multiple interconnected mechanisms. The chronic metabolic acidosis in uremia directly damages bone through a fundamental buffering mechanism. When blood pH drops due to the kidneys' inability to excrete acid, the body desperately needs to neutralize these excess protons. Bone serves as the body's largest alkaline reservoir—calcium carbonate and calcium phosphate in the bone matrix act as buffers, releasing calcium and carbonate ions to neutralize the acidic environment. This chronic process progressively weakens bone structure, contributing directly to renal osteodystrophy. This makes option A correct. Option B is incorrect because acidosis doesn't directly stimulate PTH release—rather, the hypocalcemia that results from the bone buffering process stimulates PTH secretion. Option C misrepresents the timeline and mechanism; while uremia does impair 1-alpha-hydroxylase activity and reduce calcitriol synthesis, this isn't the direct effect of acidosis itself, but rather a consequence of progressive kidney damage. Option D describes a real phenomenon in uremia (PTH resistance), but this skeletal resistance develops due to uremic toxins and altered receptor sensitivity, not directly from acidosis. Remember that renal osteodystrophy involves multiple pathways working simultaneously: acidosis causing bone buffering, hyperphosphatemia, hypocalcemia, reduced calcitriol synthesis, and secondary hyperparathyroidism. Questions often test whether you can distinguish these individual mechanisms from the overall syndrome.

Question 3

Many of the systemic effects of uremia are attributed to the accumulation of 'uremic toxins.' Which statement accurately describes the origin of many of the most pathogenic protein-bound uremic toxins, such as indoxyl sulfate and p-cresyl sulfate?

  1. They are byproducts of incomplete metabolism of fatty acids in the liver.
  2. They are generated from the breakdown of purines and pyrimidines.
  3. They are produced from dietary amino acids by the intestinal microbiome. (correct answer)
  4. They are released directly from damaged renal tubular cells during the progression of CKD.
Explanation: A significant number of uremic toxins, particularly the protein-bound solutes that are poorly cleared by dialysis, originate from the metabolic activity of the gut microbiota. For example, gut bacteria metabolize dietary tryptophan to indole and tyrosine to p-cresol. These compounds are absorbed into the bloodstream, conjugated in the liver to indoxyl sulfate and p-cresyl sulfate, and are then normally excreted by the kidneys. In renal failure, these toxins accumulate to high levels and contribute to cardiovascular disease, inflammation, and progression of CKD.

Question 4

In a patient with early to moderate chronic kidney disease (e.g., GFR 45 mL/min/1.73m²), serum phosphate levels are often maintained within the normal range despite a reduction in GFR. Which hormone is primarily responsible for this compensation by increasing the fractional excretion of phosphate?

  1. Parathyroid hormone (PTH).
  2. Fibroblast growth factor-23 (FGF-23). (correct answer)
  3. Calcitonin.
  4. Angiotensin II.
Explanation: One of the earliest adaptations to declining GFR is a rise in Fibroblast Growth Factor-23 (FGF-23), which is secreted by osteocytes in response to phosphate retention. FGF-23 is a potent phosphaturic hormone that acts on the proximal renal tubule to downregulate sodium-phosphate cotransporters, thereby increasing the fractional excretion of phosphate. This powerful compensatory mechanism maintains normal serum phosphate levels until CKD is advanced. While PTH also promotes phosphate excretion, FGF-23 is now understood to be the earlier and more primary regulator in this context.

Question 5

A 72-year-old woman with a GFR of 12 mL/min/1.73m² is brought to her nephrologist by her family, who report she has become increasingly apathetic, irritable, and has difficulty with concentration over the past few months. She has no focal neurological deficits. An EEG shows intermittent bursts of generalized, high-amplitude, slow-wave activity. Which of the following is the most likely diagnosis?

  1. Wernicke's encephalopathy due to malnutrition.
  2. Multi-infarct dementia from accelerated atherosclerosis.
  3. Uremic encephalopathy. (correct answer)
  4. Dialysis disequilibrium syndrome.
Explanation: The clinical presentation of subacute, progressive global cognitive dysfunction (apathy, poor concentration, irritability) in a patient with severe CKD is highly suggestive of uremic encephalopathy. The diagnosis is further supported by the characteristic EEG finding of intermittent, generalized slow-wave bursts (sometimes called triphasic waves), which is a classic sign of metabolic encephalopathy. The other options are less likely: Wernicke's encephalopathy typically involves ataxia and ophthalmoplegia; multi-infarct dementia often has a stepwise progression and focal deficits; and dialysis disequilibrium syndrome is an acute event related to a dialysis session.

Question 6

Patients with uremia are often described as being in a state of 'immunodeficiency,' leading to increased susceptibility to infections. Which of the following findings best characterizes this immune defect?

  1. Impaired function of neutrophils and monocytes, including defective phagocytosis and chemotaxis. (correct answer)
  2. A profound decrease in the absolute number of circulating lymphocytes and neutrophils.
  3. Failure of B-cells to produce antibodies in response to antigenic challenge.
  4. Depletion of complement proteins due to chronic activation by uremic toxins.
Explanation: When you encounter questions about uremia and immunodeficiency, focus on the functional rather than quantitative aspects of immune dysfunction. Uremia creates a complex immunosuppressed state primarily through impaired cellular function rather than depleted cell numbers. The correct answer is A because uremic toxins directly compromise the functional capacity of phagocytic cells. Neutrophils and monocytes in uremic patients show defective chemotaxis (poor migration to infection sites), impaired phagocytosis (reduced ability to engulf pathogens), and decreased bactericidal activity. These functional defects occur even when cell counts appear normal, explaining why uremic patients develop frequent infections despite having adequate numbers of immune cells. Option B is incorrect because uremia typically doesn't cause severe quantitative depletion of white blood cells. Patients may have mild lymphopenia, but profound decreases in both lymphocytes and neutrophils aren't characteristic of uremic immunodeficiency. Option C misrepresents the primary defect. While uremic patients may have some alterations in antibody responses, B-cell dysfunction isn't the predominant mechanism of immunodeficiency. The cellular immune system bears the brunt of uremic toxin effects. Option D incorrectly suggests complement depletion. Complement levels are generally normal or even elevated in uremic patients, and complement dysfunction isn't the main driver of increased infection susceptibility. Remember: In uremia-related immunodeficiency questions, think "function over numbers." The cells are present but can't perform their jobs effectively due to uremic toxin interference with cellular metabolism and signaling pathways.

Question 7

A patient's GFR declines from 60 to 20 mL/min/1.73m² over several years. Despite this significant drop in renal function, their serum potassium remains in the normal range until the GFR falls below 15 mL/min/1.73m². What is the primary compensatory mechanism that allows for maintenance of potassium homeostasis until very advanced renal failure?

  1. Increased reabsorption of potassium in the proximal tubule to conserve it.
  2. Enhanced secretion of potassium by the colon and sweat glands.
  3. Upregulation of potassium secretion in the remaining functional nephrons. (correct answer)
  4. Shifting of potassium from the extracellular to the intracellular space via insulin.
Explanation: The kidneys have a remarkable ability to adapt to maintain potassium balance. As the number of functional nephrons decreases, the surviving nephrons undergo significant adaptation. Mediated by factors like increased aldosterone and elevated plasma potassium, there is an increase in the number and activity of secretory potassium channels (ROMK and BK) in the principal cells of the distal tubule and collecting duct. This results in a dramatic increase in the rate of potassium secretion per nephron, which compensates for the loss of overall GFR. This adaptation is so effective that hyperkalemia typically does not develop until GFR is severely reduced (<15-20 mL/min). While colonic secretion also increases, the renal adaptation is the primary mechanism.

Question 8

A long-term hemodialysis patient undergoes a bone biopsy for persistent bone pain. The biopsy reveals a marked increase in unmineralized osteoid and significantly reduced bone turnover. Serum PTH levels are noted to be inappropriately low for their degree of renal failure. Which form of renal osteodystrophy is most likely present?

  1. Osteitis fibrosa cystica.
  2. Adynamic bone disease. (correct answer)
  3. Osteomalacia.
  4. Mixed uremic osteodystrophy.
Explanation: The key findings are significantly reduced bone turnover and inappropriately low PTH. This combination is the hallmark of adynamic bone disease. In this condition, both osteoblast and osteoclast activity are suppressed, leading to a low rate of bone formation and resorption. This makes the bone brittle and unable to buffer calcium and phosphate effectively. It is often caused by over-suppression of the parathyroid glands with calcium-based phosphate binders or vitamin D analogs. Osteitis fibrosa cystica is a high-turnover state due to severe hyperparathyroidism. Osteomalacia also features increased osteoid but is primarily a mineralization defect, while adynamic bone disease is a problem of low cellular activity.

Question 9

A major contributor to the exceedingly high cardiovascular mortality in patients with ESRD is vascular calcification. The pathological process of this calcification most closely resembles:

  1. Dystrophic calcification in necrotic tissue.
  2. Metastatic calcification due to simple supersaturation of calcium and phosphate.
  3. An active, cell-mediated process similar to osteogenesis. (correct answer)
  4. Senile calcification associated with aging and elastin fiber degradation.
Explanation: Uremic vascular calcification is not a passive process of mineral precipitation. It is an active, highly regulated biological process in which vascular smooth muscle cells (VSMCs) undergo a phenotypic transformation into osteoblast-like cells. Driven by factors prevalent in uremia like hyperphosphatemia, inflammation, and uremic toxins, these transformed cells express bone-related proteins (e.g., Runx2, osteocalcin), secrete a matrix vesicle-rich extracellular matrix, and actively promote mineralization, essentially forming bone within the vessel wall. This process is analogous to osteogenesis (bone formation).

Question 10

A patient with Stage 5 CKD has a hemoglobin of 8.5 g/dL. They are started on an erythropoiesis-stimulating agent (ESA) and supplemental iron. After 3 months, their hemoglobin remains below 9.0 g/dL, and their ferritin level is 600 ng/mL with a transferrin saturation (TSAT) of 15%. Which of the following best explains the patient's poor response to ESA therapy?

  1. Inadequate iron stores to support erythropoiesis.
  2. Presence of an underlying inflammatory state inhibiting iron utilization. (correct answer)
  3. Development of antibodies against the erythropoiesis-stimulating agent.
  4. Insufficient dialysis adequacy leading to suppression of bone marrow by uremic toxins.
Explanation: This patient's iron studies show a high ferritin level (>500 ng/mL) but a low transferrin saturation (<20%). This pattern is characteristic of functional iron deficiency, also known as anemia of inflammation. Uremia is a pro-inflammatory state that increases hepcidin levels, which in turn causes iron to be sequestered within the reticuloendothelial system. Although total body iron stores are adequate (high ferritin), the iron is not available for transport to the bone marrow for erythropoiesis (low TSAT), leading to ESA resistance.

Question 11

A patient with uremia develops gingival bleeding and large ecchymoses after a minor fall. A coagulation panel reveals a normal platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). Which of the following is the primary cause of this patient's bleeding tendency?

  1. Impaired production of clotting factors by the liver due to uremic toxins.
  2. Decreased platelet production from the bone marrow.
  3. Autoantibodies against platelet surface glycoproteins.
  4. Defective platelet adhesion and aggregation due to circulating uremic toxins. (correct answer)
Explanation: Uremic bleeding is primarily due to a qualitative platelet defect (thrombocytopathy), not a quantitative one. The normal platelet count rules out decreased production or increased destruction. The normal PT and aPTT rule out defects in the coagulation cascade. Uremic toxins, particularly guanidinosuccinic acid, interfere with platelet function by impairing the binding of von Willebrand factor to glycoprotein Ib and fibrinogen to glycoprotein IIb/IIIa. This leads to defective adhesion to injured endothelium and poor aggregation, resulting in a prolonged bleeding time and clinical bleeding despite normal standard coagulation studies.

Question 12

A patient on hemodialysis complains of severe, debilitating generalized pruritus that is worse during and immediately after dialysis sessions. The patient's serum calcium, phosphate, and PTH levels are within the target range for ESRD. Which of the following is the most likely underlying mechanism for this patient's pruritus?

  1. Dermal deposition of calcium phosphate crystals.
  2. Proliferation of mast cells in the skin with excessive histamine release.
  3. Uremic frost formation causing direct irritation of cutaneous nerve endings.
  4. Systemic inflammation and a T-helper 1 (Th1) predominant immune response. (correct answer)
Explanation: When you encounter uremic pruritus questions, focus on the underlying inflammatory mechanisms rather than simple metabolite accumulation theories. This patient's pruritus represents uremic pruritus, a complex inflammatory condition affecting dialysis patients. Despite normal calcium, phosphate, and PTH levels, the patient experiences severe itching that worsens during dialysis. This pattern points to systemic inflammation as the culprit. In ESRD patients, chronic uremia triggers a pro-inflammatory state characterized by elevated cytokines like IL-2 and interferon-γ, creating a Th1-predominant immune response. This inflammatory cascade sensitizes cutaneous nerve fibers and alters itch perception pathways, explaining why the pruritus persists even when traditional uremic toxins are controlled. Option A is incorrect because calcium-phosphate crystal deposition typically occurs when these minerals are elevated, but this patient's levels are within target range. Option B misrepresents the mechanism—uremic pruritus involves T-cell mediated inflammation, not mast cell proliferation and histamine release, which is why antihistamines are often ineffective in these patients. Option C describes uremic frost, a rare manifestation of severe uremia involving urea crystal formation on skin, but this patient is receiving regular dialysis and wouldn't have the extreme uremia necessary for frost formation. Remember that uremic pruritus often persists despite adequate dialysis and normal lab values because it's driven by chronic inflammation rather than simple toxin accumulation. Look for the temporal relationship with dialysis sessions and normal mineral metabolism as clues pointing toward inflammatory mechanisms.

Question 13

A patient with Stage 5 CKD not yet on dialysis is noted to have fasting hyperglycemia. The patient has no prior history of diabetes. Which mechanism best explains this finding in the context of uremia?

  1. Decreased renal clearance of insulin, leading to relative insulin excess.
  2. Pancreatic beta-cell dysfunction and decreased insulin secretion.
  3. Increased hepatic gluconeogenesis stimulated by excess glucagon.
  4. Post-receptor defects in insulin signaling pathways in peripheral tissues. (correct answer)
Explanation: When you encounter hyperglycemia in advanced CKD patients without prior diabetes, you're dealing with uremic toxin-induced insulin resistance, a key pathophysiologic consequence of kidney failure. The correct mechanism is D) Post-receptor defects in insulin signaling pathways in peripheral tissues. In Stage 5 CKD, accumulated uremic toxins directly impair insulin signaling at the cellular level. These toxins interfere with insulin receptor substrate proteins and downstream signaling cascades in muscle and fat cells, preventing glucose uptake despite adequate insulin levels. This creates a state of insulin resistance where insulin is present but cannot effectively facilitate glucose entry into cells. A) Decreased renal clearance of insulin is actually true in CKD, but this would theoretically improve glucose control by maintaining higher insulin levels, not cause hyperglycemia. The insulin resistance from uremic toxins overwhelms this effect. B) Pancreatic beta-cell dysfunction can occur in very advanced uremia, but it's typically a later finding. The primary mechanism causing hyperglycemia in CKD is peripheral insulin resistance, not inadequate insulin production. C) Increased hepatic gluconeogenesis from excess glucagon isn't the primary driver here. While some metabolic derangements occur in uremia, the dominant mechanism is the direct toxic effect on peripheral insulin sensitivity. Study tip: Remember that uremic toxins are the villains in advanced CKD complications. When you see unexplained metabolic problems in Stage 4-5 CKD patients, think about how accumulated toxins are disrupting normal cellular processes—in this case, insulin signaling.

Question 14

Patients with uremia are often described as being in a state of 'immunodeficiency,' leading to increased susceptibility to infections. Which of the following findings best characterizes this immune defect?

  1. Impaired function of neutrophils and monocytes, including defective phagocytosis and chemotaxis. (correct answer)
  2. A profound decrease in the absolute number of circulating lymphocytes and neutrophils.
  3. Failure of B-cells to produce antibodies in response to antigenic challenge.
  4. Depletion of complement proteins due to chronic activation by uremic toxins.
Explanation: When you encounter questions about uremia and immunodeficiency, focus on the functional rather than quantitative aspects of immune dysfunction. Uremia creates a complex immunosuppressed state primarily through impaired cellular function rather than depleted cell numbers. The correct answer is A because uremic toxins directly compromise the functional capacity of phagocytic cells. Neutrophils and monocytes in uremic patients show defective chemotaxis (poor migration to infection sites), impaired phagocytosis (reduced ability to engulf pathogens), and decreased bactericidal activity. These functional defects occur even when cell counts appear normal, explaining why uremic patients develop frequent infections despite having adequate numbers of immune cells. Option B is incorrect because uremia typically doesn't cause severe quantitative depletion of white blood cells. Patients may have mild lymphopenia, but profound decreases in both lymphocytes and neutrophils aren't characteristic of uremic immunodeficiency. Option C misrepresents the primary defect. While uremic patients may have some alterations in antibody responses, B-cell dysfunction isn't the predominant mechanism of immunodeficiency. The cellular immune system bears the brunt of uremic toxin effects. Option D incorrectly suggests complement depletion. Complement levels are generally normal or even elevated in uremic patients, and complement dysfunction isn't the main driver of increased infection susceptibility. Remember: In uremia-related immunodeficiency questions, think "function over numbers." The cells are present but can't perform their jobs effectively due to uremic toxin interference with cellular metabolism and signaling pathways.

Question 15

In a patient with early to moderate chronic kidney disease (e.g., GFR 45 mL/min/1.73m²), serum phosphate levels are often maintained within the normal range despite a reduction in GFR. Which hormone is primarily responsible for this compensation by increasing the fractional excretion of phosphate?

  1. Parathyroid hormone (PTH).
  2. Fibroblast growth factor-23 (FGF-23). (correct answer)
  3. Calcitonin.
  4. Angiotensin II.
Explanation: One of the earliest adaptations to declining GFR is a rise in Fibroblast Growth Factor-23 (FGF-23), which is secreted by osteocytes in response to phosphate retention. FGF-23 is a potent phosphaturic hormone that acts on the proximal renal tubule to downregulate sodium-phosphate cotransporters, thereby increasing the fractional excretion of phosphate. This powerful compensatory mechanism maintains normal serum phosphate levels until CKD is advanced. While PTH also promotes phosphate excretion, FGF-23 is now understood to be the earlier and more primary regulator in this context.

Question 16

Many of the systemic effects of uremia are attributed to the accumulation of 'uremic toxins.' Which statement accurately describes the origin of many of the most pathogenic protein-bound uremic toxins, such as indoxyl sulfate and p-cresyl sulfate?

  1. They are byproducts of incomplete metabolism of fatty acids in the liver.
  2. They are generated from the breakdown of purines and pyrimidines.
  3. They are produced from dietary amino acids by the intestinal microbiome. (correct answer)
  4. They are released directly from damaged renal tubular cells during the progression of CKD.
Explanation: A significant number of uremic toxins, particularly the protein-bound solutes that are poorly cleared by dialysis, originate from the metabolic activity of the gut microbiota. For example, gut bacteria metabolize dietary tryptophan to indole and tyrosine to p-cresol. These compounds are absorbed into the bloodstream, conjugated in the liver to indoxyl sulfate and p-cresyl sulfate, and are then normally excreted by the kidneys. In renal failure, these toxins accumulate to high levels and contribute to cardiovascular disease, inflammation, and progression of CKD.

Question 17

A 72-year-old woman with a GFR of 12 mL/min/1.73m² is brought to her nephrologist by her family, who report she has become increasingly apathetic, irritable, and has difficulty with concentration over the past few months. She has no focal neurological deficits. An EEG shows intermittent bursts of generalized, high-amplitude, slow-wave activity. Which of the following is the most likely diagnosis?

  1. Wernicke's encephalopathy due to malnutrition.
  2. Multi-infarct dementia from accelerated atherosclerosis.
  3. Uremic encephalopathy. (correct answer)
  4. Dialysis disequilibrium syndrome.
Explanation: The clinical presentation of subacute, progressive global cognitive dysfunction (apathy, poor concentration, irritability) in a patient with severe CKD is highly suggestive of uremic encephalopathy. The diagnosis is further supported by the characteristic EEG finding of intermittent, generalized slow-wave bursts (sometimes called triphasic waves), which is a classic sign of metabolic encephalopathy. The other options are less likely: Wernicke's encephalopathy typically involves ataxia and ophthalmoplegia; multi-infarct dementia often has a stepwise progression and focal deficits; and dialysis disequilibrium syndrome is an acute event related to a dialysis session.

Question 18

A 68-year-old male with ESRD complains of burning pain and numbness in his feet that has been progressing slowly. On examination, he has decreased sensation to pinprick and vibration in a 'stocking' distribution and absent ankle reflexes. What is the most likely underlying pathology?

  1. Segmental demyelination of large motor and sensory neurons.
  2. Ischemic mononeuropathy multiplex due to advanced vascular disease.
  3. Length-dependent axonal degeneration affecting sensory fibers more than motor fibers. (correct answer)
  4. Compression neuropathy of the common peroneal nerve.
Explanation: The clinical presentation describes a classic distal, symmetric polyneuropathy, which is characteristic of uremic neuropathy. The underlying pathology is a length-dependent axonal degeneration, meaning the longest nerves (those supplying the feet) are affected first. Sensory fibers are typically involved earlier and more severely than motor fibers, leading to the 'stocking' pattern of sensory loss and neuropathic pain. Absent ankle reflexes are an early sign due to the involvement of long sensory and motor fibers. While some demyelination can occur, the primary process is axonal loss.

Question 19

A patient with Stage 4 CKD has the following arterial blood gas results: pH 7.28, PaCO₂ 32 mmHg, HCO₃⁻ 15 mEq/L. Serum electrolytes are Na⁺ 138, K⁺ 5.2, Cl⁻ 108. What is the primary acid-base disturbance and the underlying renal mechanism?

  1. High anion gap metabolic acidosis due to impaired excretion of metabolic acids. (correct answer)
  2. Normal anion gap metabolic acidosis due to impaired bicarbonate reabsorption.
  3. Respiratory acidosis with metabolic compensation due to uremic pneumonitis.
  4. High anion gap metabolic acidosis due to lactic acidosis from tissue hypoxia.
Explanation: This question requires a two-step analysis. First, interpreting the ABG: the low pH (7.28) and low bicarbonate (HCO₃⁻ 15) indicate a metabolic acidosis. The low PaCO₂ (32) indicates appropriate respiratory compensation. Second, calculating the anion gap: AG = Na⁺ - (Cl⁻ + HCO₃⁻) = 138 - (108 + 15) = 15. A normal anion gap is typically 8-12 mEq/L, so this is an elevated or high anion gap metabolic acidosis (HAGMA). In advanced CKD, the primary cause of HAGMA is the kidney's failure to excrete the daily load of non-volatile acids (e.g., sulfates, phosphates, urates), which accumulate and consume bicarbonate.

Question 20

A 65-year-old male with end-stage renal disease (ESRD) on hemodialysis presents with persistently elevated blood pressure (180/100 mmHg) despite adherence to a three-drug antihypertensive regimen. His interdialytic weight gain is consistently high. Which pathophysiological mechanism is the primary driver of his treatment-resistant hypertension?

  1. Over-activation of the renin-angiotensin-aldosterone system (RAAS) due to renal ischemia.
  2. Sodium and water retention leading to chronic volume expansion. (correct answer)
  3. Impaired endothelial production of nitric oxide and increased endothelin-1.
  4. Sympathetic nervous system overactivity secondary to afferent signals from diseased kidneys.
Explanation: The key clinical finding is the high interdialytic weight gain, which is a direct indicator of significant fluid accumulation between dialysis sessions. In most patients with ESRD, the dominant mechanism driving hypertension is chronic volume expansion due to the kidneys' inability to excrete sodium and water. While RAAS activation, endothelial dysfunction, and sympathetic overactivity all contribute to hypertension in CKD, volume overload is the principal and most powerful mechanism, often leading to treatment resistance that is best managed by achieving an optimal dry weight through ultrafiltration.